December 16, 2025
Headlines

FDA OKs Novartis Prostate Cancer Treatment, Triples Eligible Patient Pool

Sumain Faisal01 mins

FDA approves Novartis’ Pluvicto for advanced prostate cancer patients who have received ARPI therapy.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News